Gisou Mohaddes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gisou Mohaddes has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
Fereshteh Farajdokht
Department of Physiology Tabriz University of Medical Sciences Tabriz Iran
15 shared publications- Shirin Babri
Tabriz University of Medical Sciences
11 shared publications - Mohammad Reza Alipour
Tabriz University of Medical Sciences
6 shared publications Arshad Ghaffari-Nasab
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
5 shared publications- Fereshteh Farajdokht
Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
5 shared publications Gonja Javani
Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
5 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by The Korean Geriatrics Society in Annals of Geriatric Medicine and Research
Microbiota–Brain Interactions in Dementia: Role of Diet in Neuroinflammation
Aging is one of the risk factors for dementia, a group of neurocognitive disorders characterized by a progressive decline in cognitive function. Alzheimer's disease (AD) is the most prevalent, followed by vascular dementia (VaD). Other subtypes, such as frontotemporal dementia (FTD) and Lewy body disease (LBD), are less common but exhibit distinctive symptoms related to motor deficits, behavioral changes, and neuropsychiatric disturbances. Each type of dementia is associated with specific pathological features, such as amyloid plaques in AD and tau tangles in FTD. Recent research highlights the significant role of gut microbiota in the pathogenesis of dementia. Gut dysbiosis, or an imbalance in the gut microbiota, has been linked to neuroinflammation, cognitive decline, and neurodegenerative diseases through the gut-brain axis (GBA). Key microbial species, such as Bacteroides and Firmicutes, produce metabolites that influence neuroinflammation, immune response, and the integrity of the blood-brain barrier (BBB). Short-chain fatty acids (SCFAs), such as butyrate, have anti-inflammatory effects, while tryptophan derivatives, such as indole-3-acetic acid (IAA), support intestinal barrier function and modulate neuroinflammatory pathways. Microbial-derived metabolites may serve as potential therapeutic targets to mitigate neurodegeneration, highlighting the intricate relationship between the gut microbiota and brain health. Dietary interventions, such as a balanced diet rich in fiber, antioxidants, and anti-inflammatory compounds, may help support gut health by promoting a balanced gut microbiota and reducing the risk of developing dementia. This review highlights the relationship between brain function, gut microbiota composition, and dementia, providing insights into potential dietary strategies for prevention and management.
- 7 October 2026
- Published by The Korean Geriatrics Society in Annals of Geriatric Medicine and Research
Open AccessMicrobiota–Brain Interactions in Dementia: Role of Diet in Neuroinflammation
Aging is one of the risk factors for dementia, a group of neurocognitive disorders characterized by a progressive decline in cognitive function. Alzheimer's disease (AD) is the most prevalent, followed by vascular dementia (VaD). Other subtypes, such as frontotemporal dementia (FTD) and Lewy body disease (LBD), are less common but exhibit distinctive symptoms related to motor deficits, behavioral changes, and neuropsychiatric disturbances. Each type of dementia is associated with specific pathological features, such as amyloid plaques in AD and tau tangles in FTD. Recent research highlights the significant role of gut microbiota in the pathogenesis of dementia. Gut dysbiosis, or an imbalance in the gut microbiota, has been linked to neuroinflammation, cognitive decline, and neurodegenerative diseases through the gut-brain axis (GBA). Key microbial species, such as Bacteroides and Firmicutes, produce metabolites that influence neuroinflammation, immune response, and the integrity of the blood-brain barrier (BBB). Short-chain fatty acids (SCFAs), such as butyrate, have anti-inflammatory effects, while tryptophan derivatives, such as indole-3-acetic acid (IAA), support intestinal barrier function and modulate neuroinflammatory pathways. Microbial-derived metabolites may serve as potential therapeutic targets to mitigate neurodegeneration, highlighting the intricate relationship between the gut microbiota and brain health. Dietary interventions, such as a balanced diet rich in fiber, antioxidants, and anti-inflammatory compounds, may help support gut health by promoting a balanced gut microbiota and reducing the risk of developing dementia. This review highlights the relationship between brain function, gut microbiota composition, and dementia, providing insights into potential dietary strategies for prevention and management.
- RetractionOpen Access
- 31 January 2026
- Published by Springer Nature in Biogerontology
- Vol. 27 (1) , 44
Retraction Note: Mitotherapy restores hippocampal mitochondrial function and cognitive impairment in aged male rats subjected to chronic mild stress
- 31 January 2026
- Published by Springer Nature in Biogerontology
- Vol. 27 (1) , 44
RetractionOpen AccessRetraction Note: Mitotherapy restores hippocampal mitochondrial function and cognitive impairment in aged male rats subjected to chronic mild stress
- Open Access
- 19 November 2025
- Published by Elsevier in Brain Disorders
- Vol. 20
Early diagnosis of Parkinson's disease pathogenesis using biofluidic biomarkers with a focus on α-synuclein
- 19 November 2025
- Published by Elsevier in Brain Disorders
- Vol. 20
Open AccessEarly diagnosis of Parkinson's disease pathogenesis using biofluidic biomarkers with a focus on α-synuclein
- 16 September 2025
- Published by Elsevier in Neuropharmacology
- Vol. 281, 110687
Intranasal AdipoRon improves motor function in a rat model of Parkinson's disease by promoting neurogenesis in the nigrostriatal pathway
- 16 September 2025
- Published by Elsevier in Neuropharmacology
- Vol. 281, 110687
Intranasal AdipoRon improves motor function in a rat model of Parkinson's disease by promoting neurogenesis in the nigrostriatal pathway
- 6 November 2024
- Published by Elsevier in European Journal of Pharmacology
- Vol. 985, 177111
AdipoRon improves mitochondrial homeostasis and protects dopaminergic neurons through activation of the AMPK signaling pathway in the 6-OHDA-lesioned rats
- 6 November 2024
- Published by Elsevier in European Journal of Pharmacology
- Vol. 985, 177111
AdipoRon improves mitochondrial homeostasis and protects dopaminergic neurons through activation of the AMPK signaling pathway in the 6-OHDA-lesioned rats
- Open Access
- 23 May 2024
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 30 (5) , e14719
Mesenchymal stem cell‐derived exosomes improve neurogenesis and cognitive function of mice with methamphetamine addiction: A novel treatment approach
Background: Methamphetamine (METH) is a psychostimulant substance with highly addictive and neurotoxic effects, but no ideal treatment option exists to improve METH‐induced neurocognitive deficits. Recently, mesenchymal stem cells (MSCs)‐derived exosomes have raised many hopes for treating neurodegenerative sequela of brain disorders. This study aimed to determine the therapeutic potential of MSCs‐derived exosomes on cognitive function and neurogenesis of METH‐addicted rodents.Methods: Male BALB/c mice were subjected to chronic METH addiction, followed by intravenous administration of bone marrow MSCs‐derived exosomes. Then, the spatial memory and recognition memory of animals were assessed by the Barnes maze and the novel object recognition test (NORT). The neurogenesis‐related factors, including NeuN and DCX, and the expression of Iba‐1, a microglial activation marker, were assessed in the hippocampus by immunofluorescence staining. Also, the expression of inflammatory cytokines, including TNF‐α and NF‐κB, were evaluated by western blotting.Results: The results showed that BMSCs‐exosomes improved the time spent in the target quadrant and correct‐to‐wrong relative time in the Barnes maze. Also, NORT's discrimination index (DI) and recognition index (RI) were improved following exosome therapy. Additionally, exosome therapy significantly increased the expression of NeuN and DCX in the hippocampus while decreasing the expression of inflammatory cytokines, including TNF‐α and NF‐κB. Besides, BMSC‐exosomes down‐regulated the expression of Iba‐1.Conclusion: Our findings indicate that BMSC‐exosomes mitigated METH‐caused cognitive dysfunction by improving neurogenesis and inhibiting neuroinflammation in the hippocampus.
- 23 May 2024
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 30 (5) , e14719
Open AccessMesenchymal stem cell‐derived exosomes improve neurogenesis and cognitive function of mice with methamphetamine addiction: A novel treatment approach
Background: Methamphetamine (METH) is a psychostimulant substance with highly addictive and neurotoxic effects, but no ideal treatment option exists to improve METH‐induced neurocognitive deficits. Recently, mesenchymal stem cells (MSCs)‐derived exosomes have raised many hopes for treating neurodegenerative sequela of brain disorders. This study aimed to determine the therapeutic potential of MSCs‐derived exosomes on cognitive function and neurogenesis of METH‐addicted rodents.Methods: Male BALB/c mice were subjected to chronic METH addiction, followed by intravenous administration of bone marrow MSCs‐derived exosomes. Then, the spatial memory and recognition memory of animals were assessed by the Barnes maze and the novel object recognition test (NORT). The neurogenesis‐related factors, including NeuN and DCX, and the expression of Iba‐1, a microglial activation marker, were assessed in the hippocampus by immunofluorescence staining. Also, the expression of inflammatory cytokines, including TNF‐α and NF‐κB, were evaluated by western blotting.Results: The results showed that BMSCs‐exosomes improved the time spent in the target quadrant and correct‐to‐wrong relative time in the Barnes maze. Also, NORT's discrimination index (DI) and recognition index (RI) were improved following exosome therapy. Additionally, exosome therapy significantly increased the expression of NeuN and DCX in the hippocampus while decreasing the expression of inflammatory cytokines, including TNF‐α and NF‐κB. Besides, BMSC‐exosomes down‐regulated the expression of Iba‐1.Conclusion: Our findings indicate that BMSC‐exosomes mitigated METH‐caused cognitive dysfunction by improving neurogenesis and inhibiting neuroinflammation in the hippocampus.
- Open Access
- 22 May 2024
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 30 (5) , e14752
Exosomes as a therapeutic tool to promote neurorestoration and cognitive function in neurological conditions: Achieve two ends with a single effort
Exosomes possess a significant role in intercellular communications. In the nervous system, various neural cells release exosomes that not only own a role in intercellular communications but also eliminate the waste of cells, maintain the myelin sheath, facilitate neurogenesis, and specifically assist in normal cognitive function. In neurological conditions including Parkinson's disease (PD), Alzheimer's disease (AD), traumatic brain injury (TBI), and stroke, exosomal cargo like miRNAs take part in the sequela of conditions and serve as a diagnostic tool of neurological disorders, too. Exosomes are not only a diagnostic tool but also their inhibition or administration from various sources like mesenchymal stem cells and serum, which have shown a worthy potential to treat multiple neurological disorders. In addition to neurodegenerative manifestations, cognitive deficiencies are an integral part of neurological diseases, and applying exosomes in improving both aspects of these diseases has been promising. This review discusses the status of exosome therapy in improving neurorestorative and cognitive function following neurological disease.
- 22 May 2024
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 30 (5) , e14752
Open AccessExosomes as a therapeutic tool to promote neurorestoration and cognitive function in neurological conditions: Achieve two ends with a single effort
Exosomes possess a significant role in intercellular communications. In the nervous system, various neural cells release exosomes that not only own a role in intercellular communications but also eliminate the waste of cells, maintain the myelin sheath, facilitate neurogenesis, and specifically assist in normal cognitive function. In neurological conditions including Parkinson's disease (PD), Alzheimer's disease (AD), traumatic brain injury (TBI), and stroke, exosomal cargo like miRNAs take part in the sequela of conditions and serve as a diagnostic tool of neurological disorders, too. Exosomes are not only a diagnostic tool but also their inhibition or administration from various sources like mesenchymal stem cells and serum, which have shown a worthy potential to treat multiple neurological disorders. In addition to neurodegenerative manifestations, cognitive deficiencies are an integral part of neurological diseases, and applying exosomes in improving both aspects of these diseases has been promising. This review discusses the status of exosome therapy in improving neurorestorative and cognitive function following neurological disease.
- Open Access
- 1 January 2024
- Vol. 27 (9) , 1115-1123
Effect of prenatal exposure to stress and extremely low-frequency electromagnetic field on hippocampal and serum BDNF levels in male adult rat offspring
Prenatal stress (PS) can adversely affect cognitive and psychological functions in the offspring. This study aimed to determine the effect of PS and extremely low-frequency electromagnetic field (ELF-EMF) on spatial memory, serum corticosterone, brain-derived neurotrophic factor (BDNF) concentrations, and hippocampal BDNF levels in adult male offspring. Female Wistar rats were randomly divided into four groups (n=6): Control, Stress, ELF-EMF (exposure to ELF-EMF), and S+EMF (simultaneous exposure to stress and the ELF-EMF) groups. Animals received interven-tions for 21 days before and 21 days during pregnancy (a total of 42 days). On the offspring’s 90th postnatal day (PND), spatial memory was tested using Morris Water Maze, serum Corticosterone and BDNF levels were measured by the ELISA method, and hippocampal BDNF levels were measured by Western blotting. PS did not affect spatial memory in the adult male offspring; however, it significantly (P<0.05) increased se-rum corticosterone levels compared to the control and EMF groups. Simultaneous induction of stress with ELF-EMF disrupted the memory acquisition phase. Serum and hippocampal BDNF levels increased signifi-cantly (P<0.05) in the EMF group compared to the stress group. Based on our findings, PS can increase serum corticosterone levels without affecting spatial memory. Howev-er, induction of ELF-EMF with stress has a destructive effect on spatial memory with no change in the corti-costerone levels. Compared to stress, prenatal exposure to ELF-EMF increases serum and hippocampal BDNF levels. Further studies are needed to determine the underlying mechanisms of these findings.
- 1 January 2024
- Vol. 27 (9) , 1115-1123
Open AccessEffect of prenatal exposure to stress and extremely low-frequency electromagnetic field on hippocampal and serum BDNF levels in male adult rat offspring
Prenatal stress (PS) can adversely affect cognitive and psychological functions in the offspring. This study aimed to determine the effect of PS and extremely low-frequency electromagnetic field (ELF-EMF) on spatial memory, serum corticosterone, brain-derived neurotrophic factor (BDNF) concentrations, and hippocampal BDNF levels in adult male offspring. Female Wistar rats were randomly divided into four groups (n=6): Control, Stress, ELF-EMF (exposure to ELF-EMF), and S+EMF (simultaneous exposure to stress and the ELF-EMF) groups. Animals received interven-tions for 21 days before and 21 days during pregnancy (a total of 42 days). On the offspring’s 90th postnatal day (PND), spatial memory was tested using Morris Water Maze, serum Corticosterone and BDNF levels were measured by the ELISA method, and hippocampal BDNF levels were measured by Western blotting. PS did not affect spatial memory in the adult male offspring; however, it significantly (P<0.05) increased se-rum corticosterone levels compared to the control and EMF groups. Simultaneous induction of stress with ELF-EMF disrupted the memory acquisition phase. Serum and hippocampal BDNF levels increased signifi-cantly (P<0.05) in the EMF group compared to the stress group. Based on our findings, PS can increase serum corticosterone levels without affecting spatial memory. Howev-er, induction of ELF-EMF with stress has a destructive effect on spatial memory with no change in the corti-costerone levels. Compared to stress, prenatal exposure to ELF-EMF increases serum and hippocampal BDNF levels. Further studies are needed to determine the underlying mechanisms of these findings.
- Open Access
- 1 January 2024
- Vol. 27 (1) , 114-121
Chronic stress-induced anxiety-like behavior, hippocampal oxidative, and endoplasmic reticulum stress are reversed by young plasma transfusion in aged adult rats
Objective(s): Aging and stress synergistically induce behavioral dysfunctions associated with oxidative and endoplasmic reticulum (ER) stress in brain regions. Considering the rejuvenating effects of young plasma on aging brain function, in the current study, we examined the effects of young plasma administration on anxiety-like behavior, NADH oxidase, NADPH oxidase, and ER stress markers in the hippocampus of old male rats. Materials and Methods: Young (3 months old) and aged (22 months old) rats were randomly assigned into five groups: young control (Y), aged control (A), aged rats subjected to chronic stress for four weeks (A+S), aged rats subjected to chronic stress and treated with old plasma (A+S+OP), and aged rats subjected to chronic stress and treated with young plasma (A+S+YP). Systemic injection of (1 ml) young and old plasma was performed for four weeks (3 times/week). Results: Young plasma transfusion significantly improved anxiety-like behavior in aged rats and modulated oxidative stress in the hippocampus, evidenced by the increased NADH oxidase (NOX) activity and the reduced NADPH oxidase. In addition, the levels of C/EBP homologous protein (CHOP) and Glucose-Regulated Protein 78 (GRP-78), as ER stress markers, markedly reduced in the hippocampus following the administration of young plasma. Conclusion: These findings suggest that young plasma transfusion could reverse anxiety-like behavior in stress-exposed aged rats by modulating the hippocampal oxidative and ER stress markers.
- 1 January 2024
- Vol. 27 (1) , 114-121
Open AccessChronic stress-induced anxiety-like behavior, hippocampal oxidative, and endoplasmic reticulum stress are reversed by young plasma transfusion in aged adult rats
Objective(s): Aging and stress synergistically induce behavioral dysfunctions associated with oxidative and endoplasmic reticulum (ER) stress in brain regions. Considering the rejuvenating effects of young plasma on aging brain function, in the current study, we examined the effects of young plasma administration on anxiety-like behavior, NADH oxidase, NADPH oxidase, and ER stress markers in the hippocampus of old male rats. Materials and Methods: Young (3 months old) and aged (22 months old) rats were randomly assigned into five groups: young control (Y), aged control (A), aged rats subjected to chronic stress for four weeks (A+S), aged rats subjected to chronic stress and treated with old plasma (A+S+OP), and aged rats subjected to chronic stress and treated with young plasma (A+S+YP). Systemic injection of (1 ml) young and old plasma was performed for four weeks (3 times/week). Results: Young plasma transfusion significantly improved anxiety-like behavior in aged rats and modulated oxidative stress in the hippocampus, evidenced by the increased NADH oxidase (NOX) activity and the reduced NADPH oxidase. In addition, the levels of C/EBP homologous protein (CHOP) and Glucose-Regulated Protein 78 (GRP-78), as ER stress markers, markedly reduced in the hippocampus following the administration of young plasma. Conclusion: These findings suggest that young plasma transfusion could reverse anxiety-like behavior in stress-exposed aged rats by modulating the hippocampal oxidative and ER stress markers.
- Open Access
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S90
MATERNAL STRESS-INDUCED BEHAVIORAL CHANGES DIMINISHED BY MATERNAL EXPOSURE TO AN ELECTROMAGNETIC FIELD IN MALE RAT OFFSPRING
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S90
Open AccessMATERNAL STRESS-INDUCED BEHAVIORAL CHANGES DIMINISHED BY MATERNAL EXPOSURE TO AN ELECTROMAGNETIC FIELD IN MALE RAT OFFSPRING